CAS
ACGN

CTC Alternative Strategies’s Aceragen Inc ACGN Stock Holding History

CTC Alternative Strategies’s Portfolio ACGN Stock Details ACGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-122
Closed -$67.7K – 269
2014
Q1 		$67.7K Buy
+122
New +$83.5K 0.04% 141

Other funds holding ACGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
N
Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

CTC Alternative Strategies's ACGN Position: Q2 2014 in Review

CTC Alternative Strategies sold out of Aceragen Inc (ACGN) in Q2 2014, closing a stake of 122 shares — an estimated $67.7K sold.

CTC Alternative Strategies first reported a position in ACGN in Q1 2014 and held it in 1 quarter. The position peaked at $67.7K in Q1 2014. 66 funds tracked by Wall St. Rank hold ACGN as of Q2 2014.

  • CTC Alternative Strategies reported no remaining Aceragen Inc position as of Q2 2014 after selling out during the quarter.
  • CTC Alternative Strategies sold 122 Aceragen Inc shares in Q2 2014, an estimated $67.7K.
  • CTC Alternative Strategies first reported a position in Aceragen Inc in Q1 2014 and held it in 1 quarter.
  • CTC Alternative Strategies's Aceragen Inc position peaked at $67.7K in Q1 2014.
  • 66 funds tracked by Wall St. Rank held Aceragen Inc as of Q2 2014.

Based on CTC Alternative Strategies's 13F filing for Q2 2014, filed 22 Jul 2014.